SCHEMBL7292297

SCHEMBL7292297

CC(=O)c1ccccc1NC(=O)c1ccc(C(C)(C)C)cc1

nearest known ligand 0.74

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 14/20 0.74
NPC1 O15118 1/20 0.66
ALDH1A1 P00352 1/20 0.66
GLA P06280 1/20 0.66
RAB9A P51151 1/20 0.66
ATM Q13315 1/20 0.66
L3MBTL1 Q9Y468 1/20 0.66
PPARG P37231 9/20 0.65
PPARA Q07869 5/20 0.62
CA1 P00915 1/20 0.61
CA2 P00918 1/20 0.61
PPARD Q03181 1/20 0.59
MAPT P10636 1/20 0.58
RECQL P46063 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6105957 0.88 NR1H4 (0.78) NR1H4NPC1ALDH1A1GLARAB9A
SCHEMBL5226864 0.87 NR1H4 (0.77) NR1H4PPARGPPARAPPARD
SCHEMBL7302098 0.86 PDCD1 (0.68) NR1H4NPC1ALDH1A1GLARAB9A
SCHEMBL4831403 0.86 NR1H4 (0.67) NR1H4NPC1ALDH1A1GLARAB9A
SCHEMBL15176770 0.86 NPC1 (0.68) NR1H4NPC1ALDH1A1GLARAB9A
SCHEMBL15233661 0.85 POLB (0.62) NR1H4ALDH1A1RAB9AATMMAPT
SCHEMBL6108092 0.85 TSHR (0.72) NR1H4NPC1ALDH1A1GLARAB9A
SCHEMBL29050680 0.84 RAB9A (0.64) NR1H4NPC1ALDH1A1RAB9AL3MBTL1
SCHEMBL5223315 0.83 RAB9A (0.73) NR1H4NPC1ALDH1A1GLARAB9A
SCHEMBL29903436 0.83 NR1H4 (0.74) NR1H4PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7557110-B2 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine TEIJIN PHARMA LIMITED (JP) 2009-07-07 US disclosed
US-7557110-B2 MAPKAP-K2; inflammatory disease, autoimmune disease, destructive bone disorder, cancer and/or tumour growth; 5-[(trans-4-aminocyclohexyl)amino]-3-fluoro-6-methyl(pyrazolo[1,5-a]pyri- midin-7-yl)}(4-iodophenyl)amine TEIJIN PHARMA LIMITED (JP) 2009-07-07 US disclosed
EP-0358118-B1 Phenylamides - process for their preparation as well as a drug containing those compounds BOEHRINGER MANNHEIM GMBH (DE) 1994-03-16 EP disclosed
US-5135949-A Anticoagulants BOEHRINGER MANNHEIM GMBH (DE) 1992-08-04 US disclosed
EP-0358118-A1 Phenylamides - process for their preparation as well as a drug containing those compounds Roche Diagnostics GmbH (DE) 1990-03-14 EP disclosed